Other Events ·
Shareholders approve amendment increasing authorized common stock from 50 million to 500 million shares
AIDX20/20 Biolabs, Inc.
On September 16, 2026, shareholders of 20/20 Biolabs, Inc. approved an amendment to the Certificate of Incorporation at an adjourned annual meeting, increasing the authorized number of common shares from 50 million to 500 million. The proposal received 3,028,609 votes in favor, with 1,155,607 against and 72,621 abstentions out of a quorum representing 4,256,837 shares. This corporate governance change expands the company's capacity to issue equity for future financing or operational needs. The company operates in the biotechnology industry.